NORITNIELSEN ApS PHARMASOURCE: Financial statements 2023
CVR: 33266707
Source: annual report 2023, Danish Business Authority
01/10/2022 – 30/09/2023
NORITNIELSEN ApS PHARMASOURCE (CVR 33266707) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 894,277 and a net result of DKK 77,974 compared with DKK 1,495,781 the year before. That is a decrease of 75.4% compared with the year before. Equity in the 2023 report amounted to DKK 157,974. The solvency ratio was 28.1%.
- Gross Profit
- DKK 894,277
- Profit/Loss
- DKK 77,974
- Equity
- DKK 157,974
- Total Assets
- DKK 562,870
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 894K | 78K | 158K | 0 |
| 2022 | - | 3.6M | 1.5M | 2.1M | 2 |
| 2021 | - | 3M | 837K | 2.1M | 2 |
| 2020 | - | 2.9M | 805K | 2.1M | 2 |
| 2019 | - | 3.4M | 1.1M | 2.5M | 2 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout NORITNIELSEN ApS PHARMASOURCE
NORITNIELSEN ApS PHARMASOURCE was a Danish company of the type Anpartsselskab based in Farum, founded in 2010. The company has been dissolved on 1 May 2025. The company was registered under the industry Virksomhedsrådgivning og andre rådgivningsaktiviteter. The company has 1 employee (2024). In 2024, the company reported a gross profit of DKK 374,773 and a net result of DKK 22,170 compared with DKK 77,974 the year before. Equity in the 2024 report amounted to DKK 180,144.